Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Capecitabine in Esophageal Cancer
NCT00453323Phase 2Unknown
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jun 2006
- Primary completion
- Dec 2009
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, capecitabine in esophageal cancer, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
Paclitaxel Micelles for Injectioncapecitabine
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00453323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453323.